{
    "code": "01057982",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01057982",
    "time": "2018-08-31 04:33:16",
    "許可證字號": "衛署藥製字第057982號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/06\/25",
    "發證日期": "102\/06\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105798201",
    "中文品名": "安畢黴微脂粒凍晶注射劑50毫克",
    "英文品名": "Ampholipad Liposome for Injection 50mg",
    "適應症": "1.骨髓移植後併發腎毒性發生侵入性黴菌感染。2.腎功能不全之麴菌屬、念珠菌屬或囊球菌屬類的菌種感染病患。3.治療感染囊球菌腦膜炎的HIV患者。4.治療麴菌屬、念珠菌屬或是囊球菌屬類的菌種感染，或是無法用Amphotericin B Deoxycholate治癒的病患，或是腎功能不全或無法耐受Amphotericin B Deoxycholate所產生的毒性之病患。5.治療臟器的利時曼氏病。在免疫不全且患有臟器的利時曼氏病之患者使用Amphotericin B Liposome for Injection治療，在初期寄生蟲清除後仍有高復發率。6.對發燒的重度嗜中性白血球缺乏症患者可能罹患黴菌感染症之經驗療法。",
    "劑型": "243凍晶注射劑",
    "包裝": "50毫克小瓶 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "AMPHOTERICINB"
    ],
    "限制項目": "01國　產 61完成BE試驗",
    "申請商名稱": "6201123468  台灣微脂體股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0502110300  永信藥品工業股份有限公司台中幼獅廠",
        "製造廠廠址": "台中市大甲區日南里工九路27號",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812200102",
            "成分名稱": "AMPHOTERICIN B",
            "含量描述": "(potency)",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "Yellow",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "藥品外觀-Ambil057982-20150921-104-09-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057982&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "81202_AHIa Insert P2-003-106-11-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057982&Seq=004&Type=9"
        },
        {
            "title": "81202_AHIa Insert P1-003-106-11-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057982&Seq=003&Type=9"
        },
        {
            "title": "insert-Ambil 50mgx10V- 057982-21050921-104-09-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057982&Seq=002&Type=9"
        },
        {
            "title": "AHIa Label 50mg-003-v2-106-11-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057982&Seq=008&Type=8"
        },
        {
            "title": "AHIa Case 50mgx10V-003-106-11-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057982&Seq=007&Type=8"
        },
        {
            "title": "AHIa Case 50mgx1V-003-106-11-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057982&Seq=006&Type=8"
        },
        {
            "title": "label-Ambil 50mgx10V-057982-20150921-104-09-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057982&Seq=005&Type=8"
        }
    ]
}